DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Janni W, Friedl T, Fehm T. et al.
Abstract GS1-06: Extended adjuvant bisphosphonate treatment over five years in early breast cancer does not improve disease-free and overall survival compared to two years of treatment: phase III data from the SUCCESS A study.
Cancer Res 2018;
78: GS1-06-GS01-06
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.